{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:49:13Z","timestamp":1790470153279,"version":"4.1.0"},"reference-count":102,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein Cell"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s13238-015-0143-7","type":"journal-article","created":{"date-parts":[[2015,3,8]],"date-time":"2015-03-08T20:59:44Z","timestamp":1425848384000},"page":"403-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Leukemia stem cells: the root of chronic myeloid leukemia"],"prefix":"10.1093","volume":"6","author":[{"given":"Hong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,10]]},"reference":[{"key":"143_CR1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/15680096113139990083","volume":"13","author":"S Adamia","year":"2013","unstructured":"Adamia S, Pilarski PM, Bar-Natan M, Stone RM, Griffin JD (2013) Alternative splicing in chronic myeloid leukemia (CML): a novel therapeutic target. Curr Cancer Drug Targets 13:735\u2013748","journal-title":"Curr Cancer Drug Targets"},{"key":"143_CR2","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983\u20133988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"143_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jcp.21076","volume":"212","author":"ES Ang","year":"2007","unstructured":"Ang ES, Zhang P, Steer JH, Tan JW, Yip K, Zheng MH, Joyce DA, Xu J (2007) Calcium\/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL). J Cell Physiol 212:787\u2013795","journal-title":"J Cell Physiol"},{"key":"143_CR4","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4161\/cc.5.24.3573","volume":"5","author":"DJ Barnes","year":"2006","unstructured":"Barnes DJ, Melo JV (2006) Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell cycle (Georgetown, Tex.) 5:2862\u20132866","journal-title":"Cell cycle (Georgetown, Tex.)"},{"key":"143_CR5","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","volume":"83","author":"A Bedi","year":"1994","unstructured":"Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038\u20132044","journal-title":"Blood"},{"key":"143_CR6","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","volume":"101","author":"R Bhatia","year":"2003","unstructured":"Bhatia R, Holtz M, Niu N, Gray R, Snyder DS, Sawyers CL, Arber DA, Slovak ML, Forman SJ (2003) Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101:4701\u20134707","journal-title":"Blood"},{"key":"143_CR7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00277-008-0603-8","volume":"88","author":"J Bhattacharyya","year":"2009","unstructured":"Bhattacharyya J, Mihara K, Yasunaga S, Tanaka H, Hoshi M, Takihara Y, Kimura A (2009) BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia. Ann Hematol 88:333\u2013340","journal-title":"Ann Hematol"},{"key":"143_CR8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.184.3.1101","volume":"184","author":"CC Bleul","year":"1996","unstructured":"Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184:1101\u20131109","journal-title":"J Exp Med"},{"key":"143_CR9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.freeradbiomed.2009.06.022","volume":"47","author":"A Bouallegue","year":"2009","unstructured":"Bouallegue A, Pandey NR, Srivastava AK (2009) CaMKII knockdown attenuates H2O2-induced phosphorylation of ERK1\/2, PKB\/Akt, and IGF-1R in vascular smooth muscle cells. Free Radical Biol Med 47:858\u2013866","journal-title":"Free Radical Biol Med"},{"key":"143_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc2562","volume":"9","author":"CL Brooks","year":"2009","unstructured":"Brooks CL, Gu W (2009) How does SIRT1 affect metabolism, senscence and cancer? Nat Rev Cancer 9:123\u2013128","journal-title":"Nat Rev Cancer"},{"key":"143_CR11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molcel.2005.12.002","volume":"20","author":"R Cao","year":"2005","unstructured":"Cao R, Tsukada Y, Zhang Y (2005) Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 20:845\u2013854","journal-title":"Mol Cell"},{"key":"143_CR12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/blood.V99.3.792","volume":"99","author":"J Cashman","year":"2002","unstructured":"Cashman J, Clark-Lewis I, Eaves A, Eaves C (2002) Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD\/SCID mice. Blood 99:792\u2013799","journal-title":"Blood"},{"key":"143_CR13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood-2007-03-078303","volume":"110","author":"JS Chang","year":"2007","unstructured":"Chang JS, Santhanam R, Trotta R, Neviani P, Eiring AM, Briercheck E, Ronchetti M, Roy DC, Calabretta B, Caligiuri MA, Perrotti D (2007) High levels of the BCR\/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C\/EBPalpha-driven myeloid differentiation. Blood 110:994\u20131003","journal-title":"Blood"},{"key":"143_CR14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/372179a0","volume":"372","author":"XS Chen","year":"1994","unstructured":"Chen XS, Sheller JR, Johnson EN, Funk CD (1994) Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372:179\u2013182","journal-title":"Nature"},{"key":"143_CR15","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2004-03-1114","volume":"105","author":"S Chu","year":"2005","unstructured":"Chu S, Xu H, Shah NP, Snyder DS, Forman SJ, Sawyers CL, Bhatia R (2005) Detection of BCR-ABL kinase mutations in CD34\u00a0+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment. Blood 105:2093\u20132098","journal-title":"Blood"},{"key":"143_CR16","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","volume":"107","author":"M Copland","year":"2006","unstructured":"Copland M, Hamilton A, Elrick LJ, Baird JW, Allan EK, Jordanides N, Barow M, Mountford JC, Holyoake TL (2006) Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood 107:4532\u20134539","journal-title":"Blood"},{"key":"143_CR17","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1158\/0008-5472.CAN-08-1101","volume":"68","author":"K Cramer","year":"2008","unstructured":"Cramer K, Nieborowska-Skorska M, Koptyra M, Slupianek A, Penserga ET, Eaves CJ, Aulitzky W, Skorski T (2008) BCR\/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair. Cancer Res 68:6884\u20136888","journal-title":"Cancer Res"},{"key":"143_CR18","doi-asserted-by":"crossref","first-page":"981679","DOI":"10.1155\/2009\/981679","volume":"2009","author":"B Culjkovic","year":"2009","unstructured":"Culjkovic B, Borden KL (2009) Understanding and targeting the eukaryotic translation initiation factor eIF4E in head and neck cancer. J Oncol 2009:981679","journal-title":"J Oncol"},{"key":"143_CR19","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1073\/pnas.102583199","volume":"99","author":"AB Dash","year":"2002","unstructured":"Dash AB, Williams IR, Kutok JL, Tomasson MH, Anastasiadou E, Lindahl K, Li S, Van Etten RA, Borrow J, Housman D, Druker B, Gilliland DG (2002) A murine model of CML blast crisis induced by cooperation between BCR\/ABL and NUP98\/HOXA9. Proc Natl Acad Sci U S A 99:7622\u20137627","journal-title":"Proc Natl Acad Sci U S A"},{"key":"143_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P, Trussell C, Schmitt-Graeff A, Landwerlin K, Veelken H, Warmuth M (2008) Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14:238\u2013249","journal-title":"Cancer Cell"},{"key":"143_CR21","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","volume":"112","author":"BJ Druker","year":"2008","unstructured":"Druker BJ (2008) Translation of the Philadelphia chromosome into therapy for CML. Blood 112:4808\u20134817","journal-title":"Blood"},{"key":"143_CR22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0145-2126(98)00113-1","volume":"22","author":"C Eaves","year":"1998","unstructured":"Eaves C, Cashman J, Eaves A (1998) Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia. Leuk Res 22:1085\u20131096","journal-title":"Leuk Res"},{"key":"143_CR23","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M (2008) Epigenetics in cancer. N Engl J Med 358:1148\u20131159","journal-title":"N Engl J Med"},{"key":"143_CR24","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood-2013-02-485607","volume":"122","author":"P Gallipoli","year":"2013","unstructured":"Gallipoli P, Pellicano F, Morrison H, Laidlaw K, Allan EK, Bhatia R, Copland M, Jorgensen HG, Holyoake TL (2013) Autocrine TNF-alpha production supports CML stem and progenitor cell survival and enhances their proliferation. Blood 122:3335\u20133339","journal-title":"Blood"},{"key":"143_CR25","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood-2013-12-545640","volume":"124","author":"P Gallipoli","year":"2014","unstructured":"Gallipoli P, Cook A, Rhodes S, Hopcroft L, Wheadon H, Whetton AD, Jorgensen HG, Bhatia R, Holyoake TL (2014) JAK2\/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34\u00a0+ cells in vitro and in vivo. Blood 124:1492\u20131501","journal-title":"Blood"},{"key":"143_CR26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.18632\/oncotarget.990","volume":"4","author":"JM Gerber","year":"2013","unstructured":"Gerber JM, Gucwa JL, Esopi D, Gurel M, Haffner MC, Vala M, Nelson WG, Jones RJ, Yegnasubramanian S (2013) Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations. Oncotarget 4:715\u2013728","journal-title":"Oncotarget"},{"key":"143_CR27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, Holyoake TL (2002) Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99:319\u2013325","journal-title":"Blood"},{"key":"143_CR28","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1182\/blood-2012-06-434894","volume":"120","author":"Y Gu","year":"2012","unstructured":"Gu Y, Chen T, Meng Z, Gan Y, Xu X, Lou G, Li H, Gan X, Zhou H, Tang J, Xu G, Huang L, Zhang X, Fang Y, Wang K, Zheng S, Huang W, Xu R (2012) CaMKII gamma, a critical regulator of CML stem\/progenitor cells, is a target of the natural product berbamine. Blood 120:4829\u20134839","journal-title":"Blood"},{"key":"143_CR29","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","volume":"105","author":"ML Guzman","year":"2005","unstructured":"Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, Jordan CT (2005) The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105:4163\u20134169","journal-title":"Blood"},{"key":"143_CR30","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1182\/blood-2007-05-088815","volume":"110","author":"ML Guzman","year":"2007","unstructured":"Guzman ML, Li X, Corbett CA, Rossi RM, Bushnell T, Liesveld JL, Hebert J, Young F, Jordan CT (2007) Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8). Blood 110:4436\u20134444","journal-title":"Blood"},{"key":"143_CR31","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2310\/JIM.0b013e3182281da3","volume":"59","author":"MS Hamdy","year":"2011","unstructured":"Hamdy MS, El-Haddad AM, Bahaa ENM, Makhlouf MM, Abdel-Hamid SM (2011) RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia. J Investig Med 59:1124\u20131130","journal-title":"J Investig Med"},{"key":"143_CR32","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","volume":"95","author":"SK Hobbs","year":"1998","unstructured":"Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95:4607\u20134612","journal-title":"Proc Natl Acad Sci U S A"},{"key":"143_CR33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/BJ20111256","volume":"442","author":"P Hojabrpour","year":"2012","unstructured":"Hojabrpour P, Waissbluth I, Ghaffari M, Cox ME, Duronio V (2012) CaMKII-gamma mediates phosphorylation of BAD at Ser170 to regulate cytokine-dependent survival and proliferation. Biochem 442:139\u2013149","journal-title":"Biochem"},{"key":"143_CR34","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","volume":"99","author":"MS Holtz","year":"2002","unstructured":"Holtz MS, Slovak ML, Zhang F, Sawyers CL, Forman SJ, Bhatia R (2002) Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation. Blood 99:3792\u20133800","journal-title":"Blood"},{"key":"143_CR35","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","volume":"94","author":"T Holyoake","year":"1999","unstructured":"Holyoake T, Jiang X, Eaves C, Eaves A (1999) Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94:2056\u20132064","journal-title":"Blood"},{"key":"143_CR36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y Hu","year":"2009","unstructured":"Hu Y, Chen Y, Douglas L, Li S (2009) beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia 23:109\u2013116","journal-title":"Leukemia"},{"key":"143_CR37","doi-asserted-by":"crossref","first-page":"36008","DOI":"10.1074\/jbc.M106125200","volume":"276","author":"K Hughes","year":"2001","unstructured":"Hughes K, Edin S, Antonsson A, Grundstrom T (2001) Calmodulin-dependent kinase II mediates T cell receptor\/CD3- and phorbol ester-induced activation of IkappaB kinase. J Biol Chem 276:36008\u201336013","journal-title":"J Biol Chem"},{"key":"143_CR38","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","volume":"453","author":"K Ito","year":"2008","unstructured":"Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, Rosenblatt J, Avigan DE, Teruya-Feldstein J, Pandolfi PP (2008) PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453:1072\u20131078","journal-title":"Nature"},{"key":"143_CR39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL (2004a) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351:657\u2013667","journal-title":"N Engl J Med"},{"key":"143_CR40","first-page":"531","volume":"6","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Weissman IL, Passegue E (2004b) Chronic versus acute myelogenous leukemia: a question of self-renewal. Cancer Cell 6:531\u2013533","journal-title":"Cancer Cell"},{"key":"143_CR41","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djk150","volume":"99","author":"X Jiang","year":"2007","unstructured":"Jiang X, Saw KM, Eaves A, Eaves C (2007) Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells. J Natl Cancer Inst 99:680\u2013693","journal-title":"J Natl Cancer Inst"},{"key":"143_CR42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg962","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin S (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415\u2013428","journal-title":"Nat Rev Genet"},{"key":"143_CR43","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","volume":"109","author":"HG Jorgensen","year":"2007","unstructured":"Jorgensen HG, Allan EK, Jordanides NE, Mountford JC, Holyoake TL (2007) Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34\u00a0+ CML cells. Blood 109:4016\u20134019","journal-title":"Blood"},{"key":"143_CR44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/stem.180399","volume":"18","author":"JH Kabarowski","year":"2000","unstructured":"Kabarowski JH, Witte ON (2000) Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia. Stem Cells 18:399\u2013408","journal-title":"Stem Cells"},{"key":"143_CR45","first-page":"378","volume":"54","author":"J Kaminska","year":"2008","unstructured":"Kaminska J, Klimczak-Jajor E, Bany-Laszewicz U (2008) Src kinases in the process of maturation megakryocyte progenitors. Postepy Biochem 54:378\u2013383","journal-title":"Postepy Biochem"},{"key":"143_CR46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbmt.2008.06.006","volume":"14","author":"C Karanes","year":"2008","unstructured":"Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, Porter DL, Uberti JP, King RJ, Confer DL (2008) Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 14:8\u201315","journal-title":"Biol Blood Marrow Transplant"},{"key":"143_CR47","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/S0021-9258(19)39637-1","volume":"265","author":"R Kaspar","year":"1990","unstructured":"Kaspar R, Rychlik W, White MW, Rhoads RE, Morris DR (1990) Simultaneous cytoplasmic redistribution of ribosomal protein L32 mRNA and phosphorylation of eukaryotic initiation factor 4E after mitogenic stimulation of Swiss 3T3 cells. J Biol Chem 265:3619\u20133622","journal-title":"J Biol Chem"},{"key":"143_CR48","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1200\/JCO.2008.16.9953","volume":"26","author":"JS Khorashad","year":"2008","unstructured":"Khorashad JS, de Lavallade H, Apperley JF, Milojkovic D, Reid AG, Bua M, Szydlo R, Olavarria E, Kaeda J, Goldman JM, Marin D (2008) Finding of kinase domain mutations in patients with chronic phase chronic myeloid leukemia responding to imatinib may identify those at high risk of disease progression. J Clin Oncol 26:4806\u20134813","journal-title":"J Clin Oncol"},{"key":"143_CR50","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2004-11-4349","volume":"105","author":"A Kortesidis","year":"2005","unstructured":"Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S (2005) Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105:3793\u20133801","journal-title":"Blood"},{"key":"143_CR51","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1093\/emboj\/17.13.3714","volume":"17","author":"E Kroon","year":"1998","unstructured":"Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg A-M, Sauvageau G (1998) Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO 17:3714\u20133725","journal-title":"EMBO"},{"key":"143_CR52","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","volume":"21","author":"L Li","year":"2012","unstructured":"Li L, Wang L, Li L, Wang Z, Ho Y, McDonald T et al (2012) Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell 21:266\u2013281","journal-title":"Cancer Cell"},{"key":"143_CR53","doi-asserted-by":"crossref","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","volume":"110","author":"S Lim","year":"2013","unstructured":"Lim S, Saw TY, Zhang M, Janes MR, Nacro K, Hill J, Lim AQ, Chang CT, Fruman DA, Rizzieri DA et al (2013) Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Proc Natl Acad Sci U S A. 110:E2298\u2013E2307","journal-title":"Proc Natl Acad Sci U S A."},{"key":"143_CR54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","volume":"411","author":"LA Liotta","year":"2001","unstructured":"Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375\u2013379","journal-title":"Nature"},{"key":"143_CR55","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.cub.2005.10.050","volume":"15","author":"X Liu","year":"2005","unstructured":"Liu X, Rubin JS, Kimmel AR (2005) Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol 15:1989\u20131997","journal-title":"Curr Biol"},{"key":"143_CR56","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1182\/blood-2008-03-144022","volume":"112","author":"X Liu","year":"2008","unstructured":"Liu X, Yao M, Li N, Wang C, Zheng Y, Cao X (2008) CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 112:4961\u20134970","journal-title":"Blood"},{"key":"143_CR57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s13238-011-1097-z","volume":"2","author":"X Liu","year":"2011","unstructured":"Liu X, Duan B, Cheng Z, Jia X, Mao L, Fu H, Che Y, Ou L, Liu L, Kong D (2011) SDF-1\/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell 2:845\u2013854","journal-title":"Protein Cell"},{"key":"143_CR58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0959-437X(02)00013-8","volume":"13","author":"SW Lowe","year":"2003","unstructured":"Lowe SW, Sherr CJ (2003) Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 13:77\u201383","journal-title":"Curr Opin Genet Dev"},{"key":"143_CR59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","volume":"107","author":"J Luo","year":"2001","unstructured":"Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W et al (2001) Negative control of p53 by Sir2 alpha promotes cell survival under stress. Cell 107:137\u2013148","journal-title":"Cell"},{"key":"143_CR60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.RES.0000182630.29093.0d","volume":"97","author":"WA Marganski","year":"2005","unstructured":"Marganski WA, Gangopadhyay SS, Je HD, Gallant C, Morgan KG (2005) Targeting of a novel Ca\u00a0+\u00a02\/calmodulin-dependent protein kinase II is essential for extracellular signal-regulated kinase-mediated signaling in differentiated smooth muscle cells. Circ Res 97:541\u2013549","journal-title":"Circ Res"},{"key":"143_CR61","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1073\/pnas.86.21.8417","volume":"86","author":"MW Marino","year":"1989","unstructured":"Marino MW, Pfeffer LM, Guidon PT, Donner DB (1989) Tumornecrosis factor induces phosphorylation of a 28kd mRNA cap-binding protein in human cervical carcinoma cells. Proc Natl Acad Sci U S A 86:8417\u20138421","journal-title":"Proc Natl Acad Sci U S A"},{"key":"143_CR62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood-2006-12-065599","volume":"110","author":"M Mohty","year":"2007","unstructured":"Mohty M, Yong AS, Szydlo RM, Apperley JF, Melo JV (2007) The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia. Blood 110:380\u2013383","journal-title":"Blood"},{"key":"143_CR63","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1182\/blood-2008-04-148130","volume":"112","author":"M Mohty","year":"2008","unstructured":"Mohty M, Szydlo RM, Yong AS, Apperley JF, Goldman JM, Melo JV (2008) Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia. Blood 112:2163\u20132166","journal-title":"Blood"},{"key":"143_CR64","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1101\/gad.1299505","volume":"19","author":"AV Molofsky","year":"2005","unstructured":"Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19:1432\u20131437","journal-title":"Genes Dev"},{"key":"143_CR65","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.leukres.2012.03.001","volume":"36","author":"RL Momparler","year":"2012","unstructured":"Momparler RL, Idaghdour Y, Marquez VE, Momparler LF (2012) Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation. Leuk Res 36:1049\u20131054","journal-title":"Leuk Res"},{"key":"143_CR66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.cb.11.110195.000343","volume":"11","author":"SJ Morrison","year":"1995","unstructured":"Morrison SJ, Uchida N, Weissman IL (1995) The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 11:35\u201371","journal-title":"Annu Rev Cell Dev Biol"},{"key":"143_CR67","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood.V94.12.4011","volume":"94","author":"AJ Naiyer","year":"1999","unstructured":"Naiyer AJ, Jo DY, Ahn J, Mohle R, Peichev M, Lam G, Silverstein RL, Moore MA, Rafii S (1999) Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin. Blood 94:4011\u20134019","journal-title":"Blood"},{"key":"143_CR68","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2007-02-073031","volume":"110","author":"SJ Neering","year":"2007","unstructured":"Neering SJ, Bushnell T, Sozer S, Ashton J, Rossi RM, Wang PY, Bell DR, Heinrich D, Bottaro A, Jordan CT (2007) Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 110:2578\u20132585","journal-title":"Blood"},{"key":"143_CR69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2005.10.015","volume":"8","author":"P Neviani","year":"2005","unstructured":"Neviani P, Santhanam R, Trotta R, Notari M, Blaser BW, Liu S, Mao H, Chang JS, Galietta A, Uttam A, Roy DC, Valtieri M, Bruner-Klisovic R, Caligiuri MA, Bloomfield CD, Marcucci G, Perrotti D (2005) The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR\/ABL-regulated SET protein. Cancer Cell 8:355\u2013368","journal-title":"Cancer Cell"},{"key":"143_CR70","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1172\/JCI68951","volume":"123","author":"P Neviani","year":"2013","unstructured":"Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, Ma Y, Mao HC, Zhang B, Wunderlich M, May PC, Sun C, Saddoughi SA, Bielawski J, Blum W, Klisovic RB, Solt JA, Byrd JC, Volinia S, Cortes J, Huettner CS, Koschmieder S, Holyoake TL, Devine S, Caligiuri MA, Croce CM, Garzon R, Ogretmen B, Arlinghaus RB, Chen CS, Bittman R, Hokland P, Roy DC, Milojkovic D, Apperley J, Goldman JM, Reid A, Mulloy JC, Bhatia R, Marcucci G, Perrotti D (2013) PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest 123:4144\u20134157","journal-title":"J Clin Invest"},{"key":"143_CR71","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/sj.leu.2404975","volume":"21","author":"CU Niemann","year":"2007","unstructured":"Niemann CU, Kjeldsen L, Ralfkiaer E, Jensen MK, Borregaard N (2007) Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia. Leukemia 21:2406\u20132410","journal-title":"Leukemia"},{"key":"143_CR72","first-page":"85","volume":"25","author":"PC Nowell","year":"1960","unstructured":"Nowell PC, Hungerford DA (1960) Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25:85\u2013109","journal-title":"J Natl Cancer Inst"},{"key":"143_CR73","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.1016\/j.jalz.2013.08.283","volume":"10","author":"B Olsson","year":"2014","unstructured":"Olsson B, Legros L, Guilhot F, Stromberg K, Smith J, Livesey FJ, Wilson DH, Zetterberg H, Blennow K (2014) Imatinib treatment and Abeta42 in humans. Alzheimers Dement 10:S374\u2013S380","journal-title":"Alzheimers Dement"},{"key":"143_CR74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0092-8674(01)00188-X","volume":"104","author":"E Passegue","year":"2001","unstructured":"Passegue E, Jochum W, Schorpp-Kistner M, Mohle-Steinlein U, Wagner EF (2001) Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell 104:21\u201332","journal-title":"Cell"},{"key":"143_CR75","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s13238-012-2092-8","volume":"3","author":"H Peng","year":"2012","unstructured":"Peng H, Wu Y, Duan Z, Ciborowski P, Zheng JC (2012) Proteolytic processing of SDF-1alpha by matrix metalloproteinase-2 impairs CXCR4 signaling and reduces neural progenitor cell migration. Protein Cell 3:875\u2013882","journal-title":"Protein Cell"},{"key":"143_CR76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/bies.20386","volume":"28","author":"T Quaiser","year":"2006","unstructured":"Quaiser T, Anton R, Kuhl M (2006) Kinases and G proteins join the Wnt receptor complex. BioEssays 28:339\u2013343","journal-title":"BioEssays"},{"key":"143_CR77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105\u2013111","journal-title":"Nature"},{"key":"143_CR78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14653240701218524","volume":"9","author":"K Rezvani","year":"2007","unstructured":"Rezvani K, Price DA, Brenchley JM, Kilical Y, Gostick E, Sconocchia G, Hansmann K, Kurlander R, Douek DC, Barrett AJ (2007) Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity. Cytotherapy 9:245\u2013251","journal-title":"Cytotherapy"},{"key":"143_CR79","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290\u2013293","journal-title":"Nature"},{"key":"143_CR80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcmd.2014.07.002","volume":"53","author":"NS Saudy","year":"2014","unstructured":"Saudy NS, Fawzy IM, Azmy E, Goda EF, Eneen A, Abdul SEM (2014) BMI1 gene expression in myeloid leukemias and its impact on prognosis. Blood Cells Mol Dis 53:194\u2013198","journal-title":"Blood Cells Mol Dis"},{"key":"143_CR81","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1084\/jem.20130706","volume":"210","author":"M Scheller","year":"2013","unstructured":"Scheller M, Schonheit J, Zimmermann K, Leser U, Rosenbauer F, Leutz A (2013) Cross talk between Wnt\/beta-catenin and Irf8 in leukemia progression and drug resistance. J Exp Med 210:2239\u20132256","journal-title":"J Exp Med"},{"key":"143_CR82","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/sj.leu.2404842","volume":"21","author":"A Sengupta","year":"2007","unstructured":"Sengupta A, Banerjee S (2007) Pleiotropic p27 (Kip1), BCR-ABL and leukemic stem cell: the trio in concert. Leukemia 21:2559\u20132561","journal-title":"Leukemia"},{"key":"143_CR83","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1128\/MCB.19.4.3051","volume":"19","author":"WF Shen","year":"1999","unstructured":"Shen WF, Rozenfeld S, Kwong A, Kom ves LG, Lawrence HJ, Largman C (1999) HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol Cell Biol 19:3051\u20133061","journal-title":"Mol Cell Biol"},{"key":"143_CR84","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1158\/0008-5472.CAN-07-2509","volume":"68","author":"J Si","year":"2008","unstructured":"Si J, Collins SJ (2008) Activated Ca2\u00a0+\/calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation. Cancer Res 68:3733\u20133742","journal-title":"Cancer Res"},{"key":"143_CR85","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1172\/JCI30779","volume":"117","author":"J Si","year":"2007","unstructured":"Si J, Mueller L, Collins SJ (2007) CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells. J Clin Invest 117:1412\u20131421","journal-title":"J Clin Invest"},{"key":"143_CR86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/wrna.101","volume":"3","author":"N Siddiqui","year":"2012","unstructured":"Siddiqui N, Borden KL (2012) mRNA export and cancer. Wiley Interdisciplinary Rev RNA 3:13\u201325","journal-title":"Wiley Interdisciplinary Rev RNA"},{"key":"143_CR87","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/leu.2012.294","volume":"27","author":"A Slupianek","year":"2013","unstructured":"Slupianek A, Falinski R, Znojek P, Stoklosa T, Flis S, Doneddu V, Pytel D, Synowiec E, Blasiak J, Bellacosa A, Skorski T (2013) BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability. Leukemia 27:629\u2013634","journal-title":"Leukemia"},{"key":"143_CR88","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bbrc.2004.08.169","volume":"323","author":"N Sorel","year":"2004","unstructured":"Sorel N, Bonnet ML, Guillier M, Guilhot F, Brizard A, Turhan AG (2004) Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia. Biochem Biophys Res Commun 323:728\u2013730","journal-title":"Biochem Biophys Res Commun"},{"key":"143_CR89","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1158\/1078-0432.CCR-07-0919","volume":"13","author":"G Strathdee","year":"2007","unstructured":"Strathdee G, Holyoake TL, Sim A, Parker A, Oscier DG, Melo JV, Meyer S, Eden T, Dickinson AM, Mountford JC, Jorgensen HG, Soutar R, Brown R (2007) Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 13:5048\u20135055","journal-title":"Clin Cancer Res"},{"key":"143_CR90","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1084\/jem.179.1.167","volume":"179","author":"T Tauchi","year":"1994","unstructured":"Tauchi T, Boswell HS, Leibowitz D, Broxmeyer HE (1994) Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. J Exp Med 179:167\u2013175","journal-title":"J Exp Med"},{"key":"143_CR91","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1172\/JCI38857","volume":"119","author":"JM Timmins","year":"2009","unstructured":"Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME, Tabas I (2009) Calcium\/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest 119:2925\u20132941","journal-title":"J Clin Invest"},{"key":"143_CR92","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2004.08.005","volume":"118","author":"ME Valk-Lingbeek","year":"2004","unstructured":"Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M (2004) Stem cells and cancer; the polycomb connection. Cell 118:409\u2013418","journal-title":"Cell"},{"key":"143_CR93","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1182\/blood-2006-08-040022","volume":"109","author":"Y Wang","year":"2007","unstructured":"Wang Y, Cai D, Brendel C, Barett C, Erben P, Manley PW, Hochhaus A, Neubauer A, Burchert A (2007) Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR\/ABL\u00a0+ progenitors via JAK-2\/STAT-5 pathway activation. Blood 109:2147\u20132155","journal-title":"Blood"},{"key":"143_CR94","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/onc.2012.83","volume":"32","author":"Z Wang","year":"2013","unstructured":"Wang Z, Yuan H, Roth M, Stark JM, Bhatia R, Chen WY (2013) SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells. Oncogene 32:589\u2013598","journal-title":"Oncogene"},{"key":"143_CR95","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(00)81692-X","volume":"100","author":"IL Weissman","year":"2000","unstructured":"Weissman IL (2000) Stem cells: units of development, units of regeneration, and units in evolution. Cell 100:157\u2013168","journal-title":"Cell"},{"key":"143_CR96","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0076-6879(07)00427-2","volume":"439","author":"DA Williams","year":"2008","unstructured":"Williams DA, Zheng Y, Cancelas JA (2008) Rho GTPases and regulation of hematopoietic stem cell localization. Methods Enzymol 439:365\u2013393","journal-title":"Methods Enzymol"},{"key":"143_CR97","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mehy.2007.03.040","volume":"70","author":"D Wodarz","year":"2008","unstructured":"Wodarz D (2008) Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: implications for the outcome of Imatinib treatment and discontinuation. Med Hypotheses 70:128\u2013136","journal-title":"Med Hypotheses"},{"key":"143_CR98","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1073\/pnas.1212904110","volume":"110","author":"ZF Yang","year":"2013","unstructured":"Yang ZF, Zhang H, Ma L, Peng C, Chen Y, Wang J, Green MR, Li S, Rosmarin AG (2013) GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2. Proc Natl Acad Sci U S A 110:2312\u20132317","journal-title":"Proc Natl Acad Sci U S A"},{"key":"143_CR99","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/leu.2008.161","volume":"22","author":"AS Yong","year":"2008","unstructured":"Yong AS, Keyvanfar K, Eniafe R, Savani BN, Rezvani K, Sloand EM, Goldman JM, Barrett AJ (2008) Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy. Leukemia 22:1721\u20131727","journal-title":"Leukemia"},{"key":"143_CR100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang B, Ho YW, Huang Q, Maeda T, Lin A, Lee SU, Hair A, Holyoake TL, Huettner C, Bhatia R (2012) Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell 21:577\u2013592","journal-title":"Cancer Cell"},{"key":"143_CR101","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nm1099","volume":"10","author":"L Zhao","year":"2004","unstructured":"Zhao L, Moos MP, Grabner R, Pedrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lotzer K, Huang L, Cui J, Rader DJ, Evans JF, Habenicht AJ, Funk CD (2004) The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 10:966\u2013973","journal-title":"Nat Med"},{"key":"143_CR102","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, Munchhof M, VanArsdale T, Beachy PA, Reya T (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458:776\u2013779","journal-title":"Nature"},{"key":"143_CR103","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/emmm.201201760","volume":"5","author":"J Zhu","year":"2013","unstructured":"Zhu J, Zhou L, Wu G, Konig H, Lin X, Li G, Qiu XL, Chen CF, Hu CM, Goldblatt E, Bhatia R, Chamberlin AR, Chen PL, Lee WH (2013) A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Mol Med 5:353\u2013365","journal-title":"EMBO Mol Med"}],"container-title":["Protein & Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-015-0143-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13238-015-0143-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13238-015-0143-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T06:42:41Z","timestamp":1676356961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/proteincell\/article\/6\/6\/403\/6803660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,10]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1007\/s13238-015-0143-7","relation":{},"ISSN":["1674-800X","1674-8018"],"issn-type":[{"value":"1674-800X","type":"print"},{"value":"1674-8018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,10]]}}}